Clinical signs and symptoms are an essential aspect of the diagnosis of Lym
e borreliosis. Thus, a thorough knowledge of the clinical features of the d
isease is important. Established clinical definitions could be of help in e
veryday clinical practice and especially to compare the findings of differe
nt authors or groups. The characteristic sign that permits the diagnosis of
Lyme borreliosis is a typical erythema migrans skin lesion. Highly suggest
ive manifestations are ear lobe lymphocytoma, acrodermatitis chronica atrop
hicans and Bannwarth's syndrome. The majority of other signs and symptoms a
re only suggestive and, when expressed individually, may have a very limite
d or even symbolic value for the purpose of diagnosis.
Laboratory confirmation of borrelial infection is needed, as a rule, for al
l manifestations of Lyme borreliosis with the exception of typical erythema
migrans. In clinical practice indirect laboratory methods are usually empl
oyed. Determination of borrelial IgM and IgG antibodies by immunofluorescen
ce assays or enzyme-linked immunosorbent assays has not been standardised,
and correlation of the results from different laboratories and/or different
commercial tests may be poor. Immunoblotting may solve some of the many di
lemmas but could (especially in Europe) raise additional questions in a fie
ld in which numerous uncertainties already exist. The reliability of method
s for direct detection of borrelial injection other than culture to ascerta
in spirochetes in tissue specimens is open to question.
Treatment with antibiotics is reasonable in all stages of Lyme borreliosis
and for all clinical manifestations; however, it has been most effective ea
rly in the course of the illness. The choice of antibiotic depends upon man
y factors including the efficacy, pharmacokinetic profile, side effects, ex
pected compliance and price. For the majority of manifestations the most ef
fective antibiotic, the optimal dosage, and the most appropriate duration o
f treatment have not been exactly determined.
Recommendations for the treatment of Lyme borreliosis in Slovenia are prese
nted.